“I was criticized, I exposed myself on social networks, I went to the Assembly of the Republic, wrote a petition, but I would do it again to get a cure,” says Sandra Gomes, a cancer patient, morning Post. Having survived triple-negative breast cancer for the second time, she found herself in a situation where she realized that Pembrolizumab, which enhances response to chemotherapy and increases survival, was only available to patients with cancer for the first time or in order to have access to the drug. I would have to pay thousands of euros privately. “I had a friend who died without medicine. I often thought the same thing could happen to me,” he says. But Sandra, 40, didn’t give up, she fought and managed to achieve universal and free access to the drug on the NHS for the type of cancer she has, as well as cervical cancer. uterus, rectum, esophagus, kidneys and melanoma. The drug was approved on July 7, and 15 days later Sandra began immunotherapy. “The medicine gave me hope that I could beat this cancer,” he guarantees.